-13.7%
KKR vs MRNA
+945.0%
-958.7%
-41.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.6% | +13.1% | -7.5% | +5.2% |
| 7D | +8.9% | +20.6% | -11.7% | +8.3% |
| 30D | +12.7% | +27.1% | -14.5% | +11.7% |
| 3M | -6.2% | +353.4% | -359.5% | -12.7% |
| 6M | -1.5% | +446.3% | -447.8% | -11.2% |
| YTD | -20.1% | +776.2% | -796.2% | -32.1% |
| 1Y | -13.7% | +987.9% | -1,001.6% | -31.2% |
| All | -13.7% | +945.0% | -958.7% | -31.2% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling